Orthopedics & Musculoskeletal Pain
Osteoarthritis & Musculoskeletal Inflammation
A degenerative and inflammatory synovial joint disease characterized by progressive breakdown of articular cartilage, subchondral bone remodeling, synovial hypertrophy, and chronic debilitating pain.
Primary Symptoms & Clinical Manifestations
- Joint pain exacerbated by weight-bearing and activity
- Morning joint stiffness lasting under 30 minutes
- Crepitus and reduced joint range of motion
- Peri-articular edema and bone tenderness
Known Risk Factors & Predispositions
- •Age, mechanical joint overload, and obesity
- •Previous joint injury, fractures, or sports trauma
- •Genetics and repetitive biomechanical stress
Evidence-Based Management & Protocols
01.Preferential COX-2 inhibition with gastric-protective agents (Aceclofenac)
02.Enzymatic resolution of post-traumatic edema and hematomas (Trypsin, Bromelain, Serratiopeptidase)
03.Site-specific transdermal anti-inflammatory gels avoiding systemic GI toxicity
04.Physical therapy and non-weight bearing aerobic exercises
Icon Drugs Treatment Options
APAR / APAR-S / APAR-MR Range
Aceclofenac + Paracetamol (± Serratiopeptidase / Thiocolchicoside)
Prescribing Specs
CT-Flam
Trypsin 48 mg + Bromelain 90 mg + Rutoside Trihydrate 100 mg + Aceclofenac 100 mg
Prescribing Specs
Serek-DP
Diclofenac Potassium 50 mg + Serratiopeptidase 15 mg + Paracetamol 325 mg
Prescribing Specs
Prenerve Gel
Diclofenac Diethylamine 1.16% + Linseed Oil 3% + Methyl Salicylate 10% + Menthol 5%
Prescribing Specs
Treatment must only be prescribed by authorized healthcare providers following objective diagnostic assessment.